Funder: European Commission
Due Dates: September 16, 2025 (Full application submission, 17:00 Brussels time)
Funding Amounts: €4–8 million per project | Up to 10 projects | Max project duration: 4 years
Summary: Supports early clinical development of innovative biotech therapies by multidisciplinary consortia, with a focus on SME participation and translation to EU health markets.
Key Information: At least 50% of the EU contribution must go to SMEs; max 5 beneficiaries per consortium; regulatory approval for phase I clinical study required at submission.